Members

Genomic Health, Inc.

Member Type: Diagnostic Companies

Genomic Health (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health launched its Oncotype DX colon cancer test in January 2010.

http://www.genomichealth.com/

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today




Download a Member List